Infect Chemother.
2021 Sep;53(3):568-569. 10.3947/ic.2021.0076.
Comments on the Published MetaAnalysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/ Cilastatin/Relebactam in Complicated Infections
- Affiliations
-
- 1Department of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Science, Islamic Azad University, Tehran, Iran
- 2Department of Pharmaceutical Science, Islamic Azad University, Tehran, Iran
- 3Department of Cellular and Molecular Biology, Faculty of Basic Science, University of Maragheh, Maragheh, Iran
- KMID: 2521250
- DOI: http://doi.org/10.3947/ic.2021.0076
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Reply: Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections
- Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/ Relebactam in Complicated Infections: A Meta-analysis
- Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
- Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients
- Multidrug-resistant bacteria: a national challenge requiring urgent addressal
